Abstract 3138
Background
Surveillance after curative resection for colorectal cancer with computed tomography (CT) of abdomen, pelvis and chest is a standard practice, but the optimal interval of surveillance CT is unclear. Usually recommended interval is 6 to 12 months, but in South Korea, earlier follow-up CT during adjuvant chemotherapy for stage II or III disease is a common practice. This study aimed to show clinical utility of early follow-up CT (EFCT) within 6 months after surgery.
Methods
The medical records of patients with stage II or III colorectal cancer who received oxaliplatin-based adjuvant chemotherapy between January 2011 and December 2014 in Asan Medical Center were retrospectively reviewed. Those who started adjuvant chemotherapy beyond 3 months after surgery and who were dead or lost to follow-up before 6 months after surgery were excluded. Information on the results of EFCT and subsequent treatment was obtained.
Results
In a total of 678 patients, 597 (88%) underwent EFCT. EFCT was associated with advanced stage: 78% (74/95) of stage II, 88% (317/359) of low-risk stage III (pT1-3 and N1), and 92% (206/224) of high-risk stage III (pT4 or N2) checked EFCT (p = 0.002). EFCT revealed recurrence in 6 (1%); 0 of stage II, 1 (0.3%) of low-risk stage III, and 5 (2.4%) of high-risk stage III (p = 0.132). Only 1 of 6 patients with recurrence underwent surgical resection of curative intent. There were no differences in overall survival (OS), disease-free survival (DFS), and cumulative occurrence of local treatment for DFS events according to undergoing EFCT with adjustment to age, gender, and stage.
Conclusions
Early recurrence within 6 months after surgery occurred in 1% of patients who were treated with oxaliplatin-based adjuvant chemotherapy, mostly in high-risk stage III disease. The practice of EFCT was associated with advanced stage but did not affect OS, DFS, or cumulative occurrence of local treatment. Clinical utility of EFCT seems to be low and should be discouraged especially in stage II or low-risk stage III disease.
Clinical trial identification
Legal entity responsible for the study
Asan Medical Center.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract